December 22, 2020
After months of negotiations, Congress finally passed the 2021 Consolidated Appropriations Act late Monday night. It is expected that the President will quickly sign the act into law.
The act provides approximately $325 billion in business relief, including roughly $275 billion for another round of Paycheck Protection Program funding. The act also provides answers to questions regarding the first round of PPP loans that have so far gone unanswered.
While the act is extremely lengthy (5,593 pdf pages long), we have attempted to summarize the most important sections regarding the Paycheck Protection Program. Read more…
December 21, 2020
As featured in #WorkforceWednesday: Employers considering mandatory COVID-19 vaccination programs need to address challenges. For example, how will your company handle reasonable accommodations or the potential risk of liability for health problems caused by employer-mandated vaccines? Read more.
December 17, 2020
As the first wave of COVID-19 vaccinations are being administered across the United States, employers are considering whether to mandate and/or administer the COVID-19 vaccine to employees. On December 16, 2020, the U.S. Equal Employment Opportunity Commission (“EEOC” or “Commission”) released updates to “What You Should Know About COVID-19 and the ADA, the Rehabilitation Act, and Other EEO Laws,” its Technical Assistance Questions and Answers publication, addressing potential concerns with vaccine administration and anti-discrimination laws the EEOC enforces.
December 16, 2020
Lidings Pharmaceuticals and Healthcare industry practice lawyers have authored the Pharmaceutical Advertising Country Comparative Guide – practical directory focused on the key aspects of advertising in pharmaceutical industry in Russia.
December 15, 2020
The first COVID-19 vaccines have started being shipped across the U.S. with the expectation that millions of doses will be administered over the next few weeks, with many times more over the coming months. This is unequivocally good news and reason for optimism. Meanwhile, however, the pandemic continues to spread nationwide and the numbers are rising rapidly.
December 11, 2020
The focus of this article will be on the analysis of the administrative rules associated with the marketing authorisation of medicinal products, based on the European scenario.
The aim is to find out whether or not the current regime can meet the new needs brought by the Covid-19 pandemic, since so far there is neither a vaccine nor a specific antiviral medication to prevent or treat it, despite the race to discover the drug or vaccine to “cure” it, to which substantial efforts and investment have been devoted to. Read more…
December 10, 2020
Ghost kitchens, also known as virtual kitchens, cloud kitchens or digital kitchens are restaurants without dining space that focus solely on fulfilling online orders for delivery. With a global pandemic limiting indoor dining in 2020 and 2021, a great deal of our restaurant meals will be delivered to homes by in-home food delivery. Research indicates that 31% of us use third party delivery serves at least once per week. Read more…
December 10, 2020
Many franchisors, as required by the Federal Trade Commission (FTC) Franchise Rule and applicable state franchise laws, updated their Franchise Disclosure Document (FDD) in the spring of 2020. Those FDDs included information from the franchisor’s previous fiscal year, which, in most cases, ended on Dec. 31, 2019. Many franchisors included financial performance representations (FPRs) in Item 19 of their FDD based on revenue data for franchisee and/or company-owned units from fiscal year 2019, which predated the COVID-19 pandemic. Read more…
December 9, 2020
As featured in #WorkforceWednesday: This week, we look at a new COVID-19 quarantine timeline and stricter workplace safety regulations in California.
December 7, 2020
Epstein Becker Green (“EBG”) has released Value-Based Payments: A Comprehensive State Survey.
EBG has researched, compiled, and analyzed state-specific content about the regulatory requirements involved in providers moving away from fee for service reimbursement (such as discounted fees and per diems) and towards value-based payment arrangements involving “downside” risk or insurance risk-sharing with insurers, HMOs, and other types of state-regulated health plans. Some types of risk-sharing arrangements include capitation, shared savings and losses, and percentage of premium reimbursement.